MRNA vs SNY

Moderna, Inc. against Sanofi — live side-by-side technical comparison.

Prices as of 2026-09-23T20:00:01+00:00 UTC · updates daily

Who leads right now

MRNA leads 5 of the 5 windows we measure — over 1 month MRNA is +31.1% and SNY -8.8%; over year to date MRNA is +517.5% and SNY -14.0%. The MRNA/SNY price ratio stands at 4.3713, above its 50-day average of 2.3938, and above the 200-day average of 1.3992. A ratio above its own average means MRNA is gaining on SNY; on this reading the recent edge belongs to MRNA.

Performance side by side

MRNASNY
Price$182.11 $41.66
1 day -0.2%lead -2.0%
5 days +25.1%lead -2.2%
1 month +31.1%lead -8.8%
6 months +255.1%lead -7.0%
Year to date +517.5%lead -14.0%
52-week position 94% of range 7% of range
52-week range $22.28–$192.31 $40.89–$52.68
vs 50-day average above $104.86 below $43.82
vs 200-day average above $62.57 below $45.32
RSI (14) 70 25
Next earnings 2026-11-052026-10-30

Where each one stands

MRNA — Moderna, Inc.

MRNA trades at $182.11, above its 50-day average of $104.86, and above the 200-day at $62.57. It sits at 94% of its 52-week range ($22.28–$192.31); 14-day RSI is 70, in overbought territory; an average session moves it about 6.3%. For levels, the first level overhead is $182.56 (0.2% away) and the first support below is $175.00 (3.9% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

SNY — Sanofi

SNY trades at $41.66, below its 50-day average of $43.82, and below the 200-day at $45.32. It sits at 7% of its 52-week range ($40.89–$52.68); 14-day RSI is 25, in oversold territory; an average session moves it about 1.7%. For levels, the first level overhead is $42.31 (1.6% away) and the first support below is $41.33 (0.8% down). On the checklist the page runs for every asset, 0 of 6 checks read bullish — the lean is bearish.

Which one moves harder

MRNA is the more volatile of the two — an average session moves it 6.3% against 1.7% for SNY, so an identical position size carries roughly 3.7× the daily risk.

What would change the picture

The comparison turns on those levels: MRNA clearing $182.56 or losing $175.00; SNY clearing $42.31 or losing $41.33. Until one of them gives way, the relative reading above stands.

Questions people ask about MRNA vs SNY

Which is performing better right now, MRNA or SNY?
Over the past month MRNA is +31.1% and SNY is -8.8%, so MRNA is ahead on that window. Year to date the figures are +517.5% for MRNA and -14.0% for SNY.
Is MRNA or SNY more volatile?
MRNA is the more volatile of the two — an average session moves it 6.3% against 1.7% for SNY, so an identical position size carries roughly 3.7× the daily risk.
What are the key levels for MRNA and SNY?
MRNA: resistance $182.56, support $175.00; SNY: resistance $42.31, support $41.33. Levels come from recent swing zones and round numbers, recomputed daily.
When do MRNA and SNY report next?
MRNA: 2026-11-05. SNY: 2026-10-30. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the MRNA/SNY ratio mean?
It is simply MRNA's price divided by SNY's — 4.3713 today. When the ratio rises, MRNA is outperforming; when it falls, SNY is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical reads

MRNA →
Moderna, Inc.
Full technical read: trend, levels, chart, news
SNY →
Sanofi
Full technical read: trend, levels, chart, news

Related comparisons

ABBV vs LLYLLY vs UNHDHR vs LLYLLY vs SNYEL.PA vs LLYLLY vs MRNABAYN.DE vs LLYABBV vs UNH